70121-2484 : Boruzu 3.5 mg/1.4ml Intravenous; Subcutaneous Injection
| NDC: | 70121-2484 |
| Labeler: | Amneal Pharmaceuticals LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Boruzu |
| Dosage Form: | Intravenous; Subcutaneous Injection |
| Application #: | NDA212782 |
| Rev. Date: |
NDC Package Codes:
- 70121-2484-1: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (70121‑2484‑1) / 1.4 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Bortezomib
Dosage Strength:
- 3.5 mg/1.4mL
Pharmaceutical Classes:
- Proteasome Inhibitor [EPC]
- Proteasome Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70121-2462Next: 70121-2496 >
Related Discussions:
gabantin-Bortezomib induced peripheral neuropathy(BINP)
I am a multiple myeloma patient, undergone 3 cycles of chemotherapy with bortezomib,and undergone autologus bonemarrow t... 1 reply
I am a multiple myeloma patient, undergone 3 cycles of chemotherapy with bortezomib,and undergone autologus bonemarrow t... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.